
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded troche containing epigallocatechin gallate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing epigallocatechin gallate is listed. Products containing it are filed in the directory as homeopathic products and unapproved drugs, in capsule and gel forms. None of the products listed under the name epigallocatechin gallate is in troche form. Veregen ointment, an FDA-approved botanical drug, is listed under its active ingredient sinecatechins, a green tea catechin extract that is mainly epigallocatechin gallate.
Bases for this dose form differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Epigallocatechin gallate (EGCG) is a green tea catechin, a plant polyphenol, that a pharmacy may compound when a prescriber orders it.
Epigallocatechin gallate (EGCG) is one of the most abundant catechins in green tea, made from the leaves of Camellia sinensis. Catechins are polyphenols studied for antioxidant and anti-inflammatory activity, mostly in laboratory work. No FDA-approved drug lists EGCG alone as its active ingredient; a Drugs@FDA search through openFDA returned no applications. The closest manufactured product is Veregen (sinecatechins) ointment, an FDA-approved botanical drug made from a partially purified green tea leaf extract whose catechins are mainly EGCG. It is indicated for external genital and perianal warts in immunocompetent adults. LiverTox notes that green tea extract is sold in many supplements but is not approved for any specific medical indication. A prescriber might order EGCG compounded in a form or vehicle that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
There is no FDA label for EGCG on its own, so no boxed warning applies. LiverTox calls green tea extract a well established cause of liver injury: more than 100 cases have been reported, usually within 1 to 6 months of starting, and a few ended in liver failure, transplant or death. NCCIH notes most cases involved extract tablets or capsules and that people with a certain immune-related gene variant appear more susceptible. Tell your prescriber right away about yellowing of the skin or eyes. NCCIH reports green tea may lower blood levels of nadolol and atorvastatin and interacts with raloxifene. Green tea contains caffeine; NCCIH advises asking a provider before use in pregnancy and notes caffeine passes into breast milk. On the skin, the Veregen label lists redness, itching, burning and pain as common. Talk to your prescriber or pharmacist about side effects.
EGCG shows antioxidant, anti-inflammatory and antiproliferative activity in vitro, but a 2018 review in Molecules notes that concentrations active in vitro generally exceed the plasma levels reached after oral dosing. Oral bioavailability is low (under 5% of oral tea catechins reached the circulation in rats); absorption is mainly passive and limited by MRP and P-glycoprotein efflux, and EGCG undergoes glucuronidation, sulfation and methylation in the gut and liver plus microbial ring fission. The review gives a half-life of about 5 to 5.5 hours. Labeled product: Veregen (sinecatechins ointment, NDA021902, approved 2006) for external genital and perianal warts in immunocompetent patients 18 and older; its mechanism in wart clearance is unknown. The label advises against use for urethral, intravaginal, cervical, rectal or intra-anal HPV disease or on open wounds, and against sun or UV exposure of treated areas. After a week of topical Veregen, plasma EGCG was measurable in only 2 of 20 subjects. LiverTox describes green tea liver injury as idiosyncratic, linked to HLA-B*35:01 and recurring with shorter latency on re-exposure; ALT elevations were more common with oral extract than placebo in a prospective trial. Dosing is per prescriber. LiverTox advises asking about green tea extract use in unexplained hepatocellular injury.
Wash and dry your hands. Place the troche between your cheek and gum or under your tongue, as your label directs, and let it dissolve. Do not chew or swallow it whole unless told to. Dissolving can take up to 30 minutes. Follow your label about eating or drinking around the dose.
Troches are nonaqueous, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in the closed container in a cool, dry place at room temperature, away from heat so they do not soften, and out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve